Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer
6 affiliations
- 1Centre for Research in Radiotherapy, Sherbrooke University Cancer Research Institute, Department of Medical Imaging and Radiation Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
- 2Service of Radiation Oncology, Sherbrooke University Hospital Center, Sherbrooke, Quebec, Canada
- 3Department of Radiation Oncology, Research Centre of Centre Hospitalier de l’Universite de Montreal, Montreal, Quebec, Canada
- 4Department of Pathology, Sherbrooke University Hospital Center, Sherbrooke University Cancer Research Institute, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
- 5Department of Medicine, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
- 6Sherbrooke Institute of Pharmacology, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
Abstract
The relapse rate for early-stage triple-negative breast cancer (TNBC) is significantly higher than that of other breast cancer subtypes. To reduce the relapse rate, we evaluated the relevance of targeting Rab4A to inhibit the increase in cancer cell invasion induced by radiotherapy (RT). The ability of cancer cells to invade into adjacent tissues correlates with the proteolytic activity of membrane type 1 matrix metalloproteinase (MT1-MMP) on their surface, whose turnover is regulated by Rab4A. When RAB4A was downregulated using shRNA in the TNBC cells D2A1 and MDA-MB-231, a significant reduction in the proteolytic activity of MT1-MMP and the invasion capacity of these TNBC cells were measured. Plasma samples from six early-stage TNBC patients were collected before RT and after the fourth radiation dose. Plasma samples collected during RT from three of these patients increased the invasiveness of TNBC cells, compared to plasma collected before RT. Of them, two experienced a recurrence of their cancer, while the third patient had not yet completed the 5-year follow-up. The downregulation of RAB4A inhibited the RT-induced increase in cancer cell invasion. In contrast, in the three patients who did not relapse after 5-year follow-up, plasma collected during RT did not significantly increase the invasiveness of the MDA-MB-231 cells, compared to their plasma collected before RT. The decrease in RAB4A expression did not result in a significant difference in the invasiveness of cancer cells when incubated with plasma collected before or during RT from these patients. Metastatic development was observed when D2A1 cells were preincubated before i.v. injection in Balb/c mice with plasma collected during RT from a patient who experienced early cancer relapse; this was also inhibited by downregulating RAB4A. In summary, our preliminary results generate the hypothesis that RT may increase cancer cell invasion and metastasis formation, which is associated with the Rab4A-mediated turnover of MT1-MMP on the cancer cell surface.
Related
- Exploring the immune enhancement effect of radiotherapy combined with NK cells on non-small cell lung cancer based on proteomics technology
- Miliary Brain Metastasis with Perivascular Enhancement in ALK-Positive Lung Cancer: A Rapid Recovery after Concurrent Lorlatinib and Whole-brain Radiotherapy
- The Smac mimetic drug Xevinapant sensitizes triple negative breast cancer to radiotherapy-induced cell death in a TNFα dependent manner
- Safety of concurrent immune checkpoint inhibitor therapy during postoperative radiotherapy for triple-negative breast cancer: A preliminary retrospective analysis
- Construction and validation of an identification model for frailty in maintenance hemodialysis patients using multiple machine learning algorithms: a cross-sectional study of retrospectively collected data
BibTeX
@article{paquette2026role,
title = {{Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer}},
author = {Benoit Paquette and Hélène Therriault and Isabelle Gauthier and Sawyna Provencher and Jean-Marc Bourque and Sahar Naasri and Ayman Oweida and Sameh Geha and Pascale Labrecque and Jean-Luc Parent},
journal = {PLOS One},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0329717},
url = {https://doi.org/10.1371/journal.pone.0329717},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Role of Rab4A in the enhancement of cancer cell invasion induced by plasma samples collected during radiotherapy in patients with triple-negative breast cancer
AU - Benoit Paquette
AU - Hélène Therriault
AU - Isabelle Gauthier
AU - Sawyna Provencher
AU - Jean-Marc Bourque
AU - Sahar Naasri
AU - Ayman Oweida
AU - Sameh Geha
AU - Pascale Labrecque
AU - Jean-Luc Parent
PY - 2026
DA - 2026/09/15
JO - PLOS One
DO - 10.1371/journal.pone.0329717
UR - https://doi.org/10.1371/journal.pone.0329717
AB - The relapse rate for early-stage triple-negative breast cancer (TNBC) is significantly higher than that of other breast cancer subtypes. To reduce the relapse rate, we evaluated the relevance of targeting Rab4A to inhibit the increase in cancer cell invasion induced by radiotherapy (RT). The ability of cancer cells to invade into adjacent tissues correlates with the proteolytic activity of membrane type 1 matrix metalloproteinase (MT1-MMP) on their surface, whose turnover is regulated by Rab4A. When RAB4A was downregulated using shRNA in the TNBC cells D2A1 and MDA-MB-231, a significant reduction in the proteolytic activity of MT1-MMP and the invasion capacity of these TNBC cells were measured. Plasma samples from six early-stage TNBC patients were collected before RT and after the fourth radiation dose. Plasma samples collected during RT from three of these patients increased the invasiveness of TNBC cells, compared to plasma collected before RT. Of them, two experienced a recurrence of their cancer, while the third patient had not yet completed the 5-year follow-up. The downregulation of RAB4A inhibited the RT-induced increase in cancer cell invasion. In contrast, in the three patients who did not relapse after 5-year follow-up, plasma collected during RT did not significantly increase the invasiveness of the MDA-MB-231 cells, compared to their plasma collected before RT. The decrease in RAB4A expression did not result in a significant difference in the invasiveness of cancer cells when incubated with plasma collected before or during RT from these patients. Metastatic development was observed when D2A1 cells were preincubated before i.v. injection in Balb/c mice with plasma collected during RT from a patient who experienced early cancer relapse; this was also inhibited by downregulating RAB4A. In summary, our preliminary results generate the hypothesis that RT may increase cancer cell invasion and metastasis formation, which is associated with the Rab4A-mediated turnover of MT1-MMP on the cancer cell surface.
SN - 1932-6203
ER -